Covered recipient · General Payments record
VALERIE K JACKSON
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$3,629.72
- Reported across 136 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $792.75 | 29 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $267.68 | 9 |
| ABBVIE INC. | $232.26 | 7 |
| PFIZER INC. | $70.43 | 3 |
| Exact Sciences Corporation | $68.53 | 3 |
| GlaxoSmithKline, LLC. | $34.59 | 1 |
| Lilly USA, LLC | $32.14 | 2 |
| Acerta Pharma LLC | $29.97 | 2 |
| Abbott Laboratories | $28.74 | 1 |
| Medtronic, Inc. | $28.41 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (29)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $28.74 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125236246 | CMS |
| ABBVIE INC. | $10.32 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107391056 | CMS |
| ABBVIE INC. | $26.59 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107391058 | CMS |
| ABBVIE INC. | $99.36 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107391060 | CMS |
| ABBVIE INC. | $6.84 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107391062 | CMS |
| ABBVIE INC. | $31.86 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107391064 | CMS |
| ABBVIE INC. | $33.97 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107391066 | CMS |
| ABBVIE INC. | $23.32 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107391068 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.78 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105646796 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.19 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104415869 | CMS |
| Exact Sciences Corporation | $23.29 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114715614 | CMS |
| Exact Sciences Corporation | $25.88 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114715619 | CMS |
| Exact Sciences Corporation | $19.36 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114715625 | CMS |
| GlaxoSmithKline, LLC. | $34.59 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116030080 | CMS |
| Lilly USA, LLC | $15.43 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135970662 | CMS |
| Lilly USA, LLC | $16.71 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135992548 | CMS |
| Medtronic, Inc. | $28.41 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116986337 | CMS |
| Novo Nordisk Inc | $15.01 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100322222 | CMS |
| Novo Nordisk Inc | $21.08 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100469576 | CMS |
| Novo Nordisk Inc | $15.03 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100632889 | CMS |
| Novo Nordisk Inc | $122.27 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100452620 | CMS |
| Novo Nordisk Inc | $16.75 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100476982 | CMS |
| Novo Nordisk Inc | $13.35 | 05/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100416887 | CMS |
| Novo Nordisk Inc | $23.53 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100292960 | CMS |
| Novo Nordisk Inc | $18.02 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100503557 | CMS |
| Novo Nordisk Inc | $22.64 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100514277 | CMS |
| PFIZER INC. | $23.30 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131529769 | CMS |
| PFIZER INC. | $23.30 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131577059 | CMS |
| PFIZER INC. | $23.83 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131576625 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.